EGFR,KRAS,BRAF, andHER-2molecular status in brain metastases from 77 NSCLC patients

Brain metastases: pathobiology and emerging targeted therapies

(2012) Matthias Preusser et al.   ACTA NEUROPATHOLOGICA

Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer

(2012) Robert C. Doebele et al.   CANCER

KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer

(2011) J. Tie et al.   CLINICAL CANCER RESEARCH

EGFR and KRAS mutations in metastatic lung adenocarcinomas

(2011) Delicia Munfus-McCray et al.   HUMAN PATHOLOGY

Incidence ofEGFRExon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas

(2011) Sandra P. D'Angelo et al.   JOURNAL OF CLINICAL ONCOLOGY

Heterogeneous Distribution of EGFR Mutations Is Extremely Rare in Lung Adenocarcinoma

(2011) Yasushi Yatabe et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective Molecular Marker Analyses ofEGFRandKRASFrom a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Cancer

(2011) Wolfram Brugger et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations

(2011) Antonio Marchetti et al.   JOURNAL OF CLINICAL ONCOLOGY

New driver mutations in non-small-cell lung cancer

(2011) William Pao et al.   LANCET ONCOLOGY

BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

(2011) Hazem El-Osta et al.   PLoS One

Les métastases cérébrales des cancers bronchiques non à petites cellules : vers une prise en charge homogène

(2011) O. Bailon et al.   REVUE NEUROLOGIQUE

KRAS mutation status in primary nonsmall cell lung cancer and matched metastases

(2010) Alexis B. Cortot et al.   CANCER

Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib

(2010) S. Heon et al.   CLINICAL CANCER RESEARCH

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation

(2010) R. Porta et al.   EUROPEAN RESPIRATORY JOURNAL

Personalized Medicine in Non–Small-Cell Lung Cancer: IsKRASa Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor–Targeted Therapy?

(2010) Patrick J. Roberts et al.   JOURNAL OF CLINICAL ONCOLOGY

EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer

(2010) A. F. Eichler et al.   NEURO-ONCOLOGY

Oncogenic mutations as predictive factors in colorectal cancer

(2010) A Lièvre et al.   ONCOGENE

LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition

(2009) C L Mahoney et al.   BRITISH JOURNAL OF CANCER

HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors

(2009) M. Sun et al.   CLINICAL CANCER RESEARCH

A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases

(2009) Sara E. Monaco et al.   HUMAN PATHOLOGY

Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer

(2009) Lorenzo Daniele et al.   Journal of Thoracic Oncology

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

(2009) Rafael Rosell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differential Expression of Biomarkers in Men and Women

(2009) David Planchard et al.   SEMINARS IN ONCOLOGY

Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer

(2008) C.-H. Gow et al.   ANNALS OF ONCOLOGY

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

(2008) A Kalikaki et al.   BRITISH JOURNAL OF CANCER

KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

(2008) Astrid Lièvre et al.   JOURNAL OF CLINICAL ONCOLOGY